ETON PHARMACEUTICALS INC. - COMMON STOCK

Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference

18 Oct 2022 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution

13 Sep 2022 08:00:01 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

30 Aug 2022 15:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results

11 Aug 2022 15:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022

02 Aug 2022 07:00:02 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)

18 Jul 2022 06:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Sale of Hospital Products

24 Jun 2022 06:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2022 Financial Results

12 May 2022 15:02:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022

03 May 2022 15:02:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer

11 Apr 2022 15:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection

11 Apr 2022 06:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2021 Financial Results

16 Mar 2022 15:02:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter 2021 Financial Results on Wednesday, March 16, 2022

08 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

Eton Pharmaceuticals and ANI Pharmaceuticals Announce Commercial Availability of Carglumic Acid Tablets, the First and Only FDA-Approved Generic Version of Carbaglu® (carglumic acid)

20 Dec 2021 06:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter Financial Results

15 Nov 2021 15:05:01 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Co-Promotion Agreement with Tolmar Pharmaceuticals for ALKINDI SPRINKLE®

15 Nov 2021 05:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals and Azurity Pharmaceuticals, Inc. Announce FDA Approval of EPRONTIA™ (topiramate) Oral Solution

08 Nov 2021 05:00:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021

03 Nov 2021 15:15:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of Approved Orphan Drug Product Carglumic Acid

28 Oct 2021 06:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter Financial Results

16 Aug 2021 15:02:00 By Nasdaq GlobeNewswire